EQS-Adhoc

    101 Aufrufe 101 0 Kommentare 0 Kommentare

    MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year

    Für Sie zusammengefasst
    • MeVis adjusts 2023/2024 sales forecast to €17-17.5M.
    • EBIT forecast revised down to €3-3.5M for the year.
    • Decline due to cautious purchasing, currency impacts.

    EQS-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Change in Forecast
    MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year

    04-Sep-2024 / 17:39 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.


    Bremen, September 4, 2024 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, is adjusting its annual forecast for the current fiscal year based on the preliminary business figures for the first eleven months.

    • For fiscal year 2023/2024 (October 1, 2023 to September 30, 2024), sales are now expected to remain stable at between € 17.0 million and € 17.5 million (previous forecast for fiscal year 2023/2024: slight increase in sales from € 18.0 million to € 18.5 million).
    • EBIT (earnings before interest and taxes) is now expected to fall to between € 3.0 million and € 3.5 million in fiscal year 2023/2024 (October 1, 2023 to September 30, 2024) (previous forecast for fiscal year 2023/2024: stability in the range of € 4.5 million to € 5.0 million).

    The reasons for the decline in sales are an unexpected cautiousness in purchasing behavior due to global economic challenges. In addition, the result will be strongly impacted by the development of the US dollar/euro exchange rate since the beginning of the fiscal year.

     

    ************************************************************************

     

    Contact:
    Kirchhoff, Marcus / CEO

    End of Inside Information

    04-Sep-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com


    Language: English
    Company: MeVis Medical Solutions AG
    Caroline-Herschel-Str. 1
    28359 Bremen
    Germany
    Phone: +49 421 224 95 0
    Fax: +49 421 224 95 999
    E-mail: ir@mevis.de
    Internet: http://www.mevis.de
    ISIN: DE000A0LBFE4
    WKN: A0LBFE
    Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1981763

     
    End of Announcement EQS News Service

    1981763  04-Sep-2024 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1981763&application_name=news&site_id=wallstreet~~~257e03b8-9cbc-48b8-b6a5-ec526abf7b8e 

    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year EQS-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Change in Forecast MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year 04-Sep-2024 / 17:39 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the …